Chemotherapy at the End of Life (EOL) for Patients with Lung Cancer within the VA System

被引:0
|
作者
Santana-Davila, Rafael [1 ]
Kelley, Michael J. [2 ]
Williams, Christina D. [3 ]
Eaton, Keith [1 ]
Whittle, Jeffrey C. [4 ]
机构
[1] Univ Washington, Seattle, WA 98195 USA
[2] Duke Univ, Durham, NC USA
[3] Duke Univ, Va Hosp, Durham, NC USA
[4] Med Coll Wisconsin, Milwaukee, WI 53226 USA
关键词
end of life; palliative care; chemotherapy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PUB111
引用
收藏
页码:S789 / S790
页数:2
相关论文
共 50 条
  • [1] Continuity of care for cancer patients at the end of life (EoL).
    Bascioni, R.
    Esperide, B.
    Iacopini, D.
    Basirat, F.
    Rastelli, F.
    Acito, L.
    Bisonni, R.
    Giustini, L.
    Giorgi, F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] End of life (EOL) care in patients with metastatic lung cancer harboring EGFR-mutations.
    Bauman, Jessica Ruth
    Piotrowska, Zofia
    Scribner, Emily
    Temel, Brandon
    Sequist, Lecia V.
    Heist, Rebecca Suk
    Temel, Jennifer S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Pattern of chemotherapy use at end of life (EOL) in patients with solid tumors (ST).
    Burke, Thomas W.
    DeJesus, Yvette A.
    Cheng, Lee
    Buzdar, Aman
    Rodriguez, Maria Alma
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (31)
  • [4] Chemotherapy at the end of life for patients with lung cancer. A practice analysis
    Sese, L.
    Didier, M.
    Rousseau-Bussac, G.
    Crequit, P.
    Masanes, M. J.
    Chouaid, C.
    [J]. REVUE DES MALADIES RESPIRATOIRES, 2015, 32 (03) : 256 - 261
  • [5] Administration of chemotherapy to advanced lung cancer patients near the end of life
    Watanabe, Kageaki
    Nagamata, Makoto
    Yomota, Makiko
    Zenke, Yoshitaka
    Okuma, Yusuke
    Hosomi, Yukio
    Okamura, Tatsuru
    [J]. ANNALS OF ONCOLOGY, 2017, 28 : 83 - 83
  • [6] Chemotherapy at the end of life in metastatic lung cancer
    Martin, B. E.
    Rajab, H.
    Ruud, C. O.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Factors related to end-of-life (EOL) chemotherapy in solid tumor (ST) patients
    Rodriguez, Maria Alma
    DeJesus, Yvette A.
    Cheng, Lee
    Buzdar, Aman
    Burke, Thomas W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Pattern of chemotherapy use at end-of-life (EOL) in patients with solid tumors (ST)
    Burke, Thomas W.
    DeJesus, Yvette A.
    Cheng, Lee
    Buzdar, Aman
    Rodriguez, Maria Alma
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] End of life (EOL) chemotherapy (CT) in gastro-intestinal (GI) cancer patients (pts): A retrospective AGEO study
    Lapeyre-Prost, A.
    Perkins, G.
    Vallee, M.
    Pozet, A.
    Tougeron, D.
    Maillet, M.
    Locher, C.
    Dreanic, J.
    Legoux, J. L.
    Lievre, A.
    Lecaille, C.
    Sabate, J-M.
    Mary, F.
    Bonnetain, F.
    Jaulmes-Bouillot, H.
    Landi, B.
    Taieb, J.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [10] Factors related to end-of-life (EOL) chemotherapy in solid tumor (ST) patients.
    Rodriguez, Maria Alma
    DeJesus, Yvette A.
    Cheng, Lee
    Buzdar, Aman
    Burke, Thomas W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (31)